Gary Layton

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study

Rayid Abdulqawi, Rachel Dockry, Kimberley Holt et al. · The Lancet · 2014 · 473 citations

Asthma, Placebo-controlled Phase 2, Pharmacology +6

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension

Robyn J. Barst, D. Dunbar Ivy, Guillermo Gaitan et al. · Circulation · 2011 · 365 citations · Full text

Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension

Lewis J. Rubin, David B. Badesch, Thomas R. Fleming et al. · CHEST Journal · 2011 · 252 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +9

STARTS-2

Robyn J. Barst, Maurice Beghetti, Tomás Pulido et al. · Circulation · 2014 · 206 citations · Full text

Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial

Joanna M. Zakrzewska, Joanne Palmer, Valérie Morisset et al. · The Lancet Neurology · 2017 · 188 citations · Full text

Interventional Pain Medicine, Pain Medicine, Trigeminal Neuralgia +7